A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.
Company Details
- Employees
- 11
- Founded
- 2018
- Address
- 7505 Fannin Street,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.empiricancer.com/
- Keywords
- Cancer, Single cell sequencing, Oncology, Biotech, Clinical instrumentation, Drug sensitivity.
- HQ
- Houston, Texas
Empiri Inc. Questions
Empiri Inc.'s website is https://www.empiricancer.com/
Empiri Inc.'s LinkedIn profile is https://www.linkedin.com/company/empiriinc
Empiri Inc. has
11 employees.
View email and phone details for 11
employees at Empiri Inc..
Empiri Inc.'s industry is
Biotechnology Research
Empiri Inc.'s top competitors are
Brightest Bio,
Cho Plus, Inc.,
Evoworks Bio,
Osem Fluidics,
Novilytic,
Visicell Medical Inc.,
Diagnostic Biochips, Inc.,
Advemto Ltd.,
Oxbridge Clinical,
Avenue Biosciences.
Empiri Inc.'s categories are Biotechnology Research
Empiri Inc.'s founding year is 2018
